Biophytis starts Phase II/III Covid-19 trial of Sarconeos in Belgium
Biotechnology firm Biophytis has started enrolment and dosing of patients in a Phase II/III clinical...
Biotechnology firm Biophytis has started enrolment and dosing of patients in a Phase II/III clinical...
French biotech firm Biophytis will assess its Sarconeos (BIO101) drug as a treatment for respiratory...
UCB has reported positive results from the Phase III BE READY clinical trial of its...
Themis Bioscience and the Coalition for Epidemic Preparedness Innovations (CEPI) have commenced a Phase I...
UCB has announced that the Phase III BE VIVID clinical trial of its bimekizumab met...
UK-based Vaccitech has started treating patients with influenza A vaccine MVA-NP+M1 (VTP-100) in a Phase...
MorphoSys and Galapagos have commenced a Phase II clinical trial, in alliance with Novartis Pharma,...
OSE Immunotherapeutics has secured authorisation from the French and Belgian regulatory authorities to conduct a...
Biotechnology company argenx has started dosing patients in a Phase III clinical trial of its...
FluGen has dosed the first subject in a new clinical trial evaluating the M2SR vaccine...